Passage Bio Stock Options Expiring on 15th of August

PASG Stock  USD 5.27  0.29  5.22%   
Passage Bio's latest option contracts expiring on August 15th 2025 are carrying combined implied volatility of 2.67. The Passage Bio option chain provides detailed quote and price information for the current Passage Bio option contracts. It shows all of Passage Bio's listed puts, calls, expiration dates, strike prices, and other pricing information.

Passage Bio In The Money Call Balance

When Passage Bio's strike price is surpassing the current stock price, the option contract against Passage Bio stock is said to be in the money. When it comes to buying Passage Bio's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Passage Bio are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Passage Current Options Market Mood

Passage Bio's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Passage Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Unfortunately, most Passage Bio's options investors are not very successful. Passage Bio's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Passage contract

Base on the Rule 16, the options market is currently suggesting that Passage Bio will have an average daily up or down price movement of about 0.17% per day over the life of the 2025-08-15 option contract. With Passage Bio trading at USD 5.27, that is roughly USD 0.008794. If you think that the market is fully incorporating Passage Bio's daily price movement you should consider buying Passage Bio options at the current volatility level of 2.67%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Passage Bio Option Chain

When Passage Bio's strike price is surpassing the current stock price, the option contract against Passage Bio stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Passage Bio's option chain is a display of a range of information that helps investors for ways to trade options on Passage. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Passage. It also shows strike prices and maturity days for a Passage Bio against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
PASG250815C0000750007.50.0 - 0.850.85Out
Call
PASG250815C0000500005.00.0 - 0.450.45In
Call
PASG250815C0000250012.50.0 - 1.950.03In
 Put
PASG250815P0000750007.55.7 - 7.55.7In
 Put
PASG250815P0000500005.03.2 - 5.03.2Out
 Put
PASG250815P0000250002.52.0 - 2.52.0Out

Passage Bio Market Cap Over Time

   Market Cap   
       Timeline  

Passage Total Stockholder Equity

Total Stockholder Equity

58.2 Million

At this time, Passage Bio's Total Stockholder Equity is most likely to increase significantly in the upcoming years.

Passage Bio Corporate Management

Sue BrowneSenior DevelopmentProfile
Simona KingCFO SecProfile
JD EsqGeneral SecretaryProfile
Gregory FuestVice MarketingProfile
MSc MBAChief OfficerProfile
Kathleen BorthwickPrincipal FinanceProfile
When determining whether Passage Bio is a strong investment it is important to analyze Passage Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Passage Bio's future performance. For an informed investment choice regarding Passage Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Passage Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Passage Bio. If investors know Passage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Passage Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(20.40)
Return On Assets
(0.34)
Return On Equity
(0.84)
The market value of Passage Bio is measured differently than its book value, which is the value of Passage that is recorded on the company's balance sheet. Investors also form their own opinion of Passage Bio's value that differs from its market value or its book value, called intrinsic value, which is Passage Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Passage Bio's market value can be influenced by many factors that don't directly affect Passage Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Passage Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Passage Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Passage Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.